Clemizole Hydrochloride

盐酸克立咪唑

Report date: 2026/05/15 20:01:45
NME

Base Information

Drug NameClemizole Hydrochloride
Drug Alias NameClemizole盐酸氯苄咪唑盐酸氯咪唑克立咪唑EPX-100
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor agonists
TargetsSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsLennox Gastaut SyndromeEpilepsies, MyoclonicCarcinoma, Hepatocellular +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPoland +[11
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
China Registration ClassN/A

Develop Information

Active IndicationsLennox Gastaut SyndromeEpilepsies, Myoclonic
Inactive IndicationsCarcinoma, HepatocellularHepatitis C

Other Information

ATC CodeN/A